Atlas Trials

Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Clinical trial NCT01478737 · COMPLETED

Trial details

NCT number
NCT01478737
Sponsor
Anders Kvanta
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2011-11-01
Primary completion
2016-04-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.